Global gastrointestinal endoscopic devices market worth reach approximately USD 8.5 Billion by 2021, growing at a CAGR of around 7.0% between 2016 and 2021.
The report covers forecast and analysis for the gastrointestinal endoscopic devices market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the gastrointestinal endoscopic devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the gastrointestinal endoscopic devices market on a global level.
In order to give the users of this report a comprehensive view on the gastrointestinal endoscopic devices market and to understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the gastrointestinal endoscopic devices market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view on the gastrointestinal endoscopic devices market by segmenting the market based on product segment and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the gastrointestinal endoscopic devices market has been segmented into hemostatis devices, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopes, GI videoscopes, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil.
The report also includes detailed profiles of end players such as Covidien Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Ltd., Olympus Corporation, Fujinon Ltd and Conmed Corporation. The detailed description of players includes parameters such as company overview, financial overview, business and recent developments of the company.
This report segments the global gastrointestinal endoscopic devices market as follows:
Global Gastrointestinal Endoscopic Devices Market: Product Segment Analysis
Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)
Global Gastrointestinal Endoscopic Devices Market: Regional Segment Analysis
This report is based on in-depth qualitative and quantitative analyses of the global Gastrointestinal Endoscopic Devices market. Zion Research has collected and analyzed key data belong to the global Gastrointestinal Endoscopic Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Gastrointestinal Endoscopic Devices across the world has been calculated through primary and secondary research.
Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Gastrointestinal Endoscopic Devices industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Gastrointestinal Endoscopic Devices market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
Endoscopy devices are one of the crucial devices that provide clinical solutions to the demands of the fast-paced world by allowing close examination of internal organs and body structures. As a result of changing lifestyle and increasing consumption of junk food, the gastro intestinal health issues have increased rapidly in last few years. This has led to increasing in the usage of gastrointestinal endoscopy. Gastrointestinal endoscopy devices help the doctor, to have a clear view of inside lining of the patient esophagus and the first part of the patient small intestine.
Upper endoscopy is used to treat conditions of the upper gastrointestinal tract. The scope helps the doctor to have a look if the patient has any ulcer, inflammation, tumors, infection, or bleeding. It helps to collect tissue samples (biopsy), remove polyps, and treat bleeding through the scope. It also helps to find out problems that do not show up on X-ray tests. It is more accurate than X-ray films for detecting inflammation, ulcers, and tumors of the esophagus, stomach, and duodenum.
As a result of changing lifestyle, lack of proper exercise and continuous shift of youngsters towards junk food has given rise to numerous gastrointestinal (GI) disorders which in turn is expected to drive the demand for the gastrointestinal endoscopic devices market during the forecast period. Moreover, increase in a number of patients with colon & rectum cancer, the growing geriatric population with long-term medical conditions such as GI disorders overweight & tobacco consumption are some others factors driving the growth of gastrointestinal endoscopic devices market. However, the fear of infections caused by endoscopes and chances of complications during endoscopy may curb the gastrointestinal endoscopy devices market in the near future. Moreover, lack of government funding and lack of reimbursement policies are some more factors expected to hamper the growth of the global gastrointestinal endoscopic devices market in the near future. Nonetheless, advancements in the gastrointestinal endoscopic devices are expected to open new avenues for the market over the years.
The gastrointestinal endoscopic devices market can be segmented into product segments viz. hemostasis devices, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopes, GI videoscopes, and others (esophageal dilation balloons, stents, polypectomy snares, and anti-reflux devices). GI video scores dominated the gastrointestinal endoscopic devices market in 2015 as the result of rising predominance of gastrointestinal disorders such as Crohn's diseases, ulcer, & bowel syndrome. Moreover, capsule endoscopes are also expected to witness modest growth in the coming years.
North America was the largest regional market for the gastrointestinal endoscopic U.S was the leading market for gastrointestinal endoscopic devices in North America in 2015. North America accounted for more than 30% share of the global gastrointestinal endoscopic devices market. Europe followed North America in terms of demand for gastrointestinal endoscopic devices. However, poor reimbursement policies for imaging procedures and drop in government funding in various nations such as Europe and the U.S. are few factors impeding market growth. Asia Pacific is expected to be the fastest regional market for gastrointestinal endoscopic devices on account of the rising and aging population in China, India, and Australia. In addition, the expansion of health insurance coverage in Asia Pacific is expected to increase access to healthcare, government initiative to lower direct taxes, higher depreciation on medical equipment, income tax exemption coupled with increasing medical tourism in India, Singapore and Thailand which in turn is expected to augment the demand for gastrointestinal endoscopic devices in the near future.
Major market players in this industry are Covidien Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Ltd., Fujinon Ltd and Conmed Corporation among others. The growing geriatric population is yet another reason that will impel growth in the global gastrointestinal endoscopic devices market, making it imperative for players to launch high-end endoscopic devices. Many players in the pharmaceutical sector are aiming at research & development activities in order to introduce potential breakthroughs for the development of improved and more effective gastrointestinal endoscopic devices.